| |
|
| |
Farmakol Toksikol, Vol. 51, No. 3. (n 1988), pp. 16-18.
|
| |
J. Neurosci., Vol. 25, No. 47. (23 November 2005), pp. 11045-11054.
|
| |
|
| |
|
| |
Human Psychopharmacology: Clinical and Experimental, Vol. 12, No. 6. (1997), pp. 547-556.
|
| |
Cancer cell, Vol. 11, No. 1. (January 2007), pp. 37-51.
by Sébastien Bonnet, Stephen L. Archer, Joan Allalunis-Turner, et al.Alois Haromy, Christian Beaulieu, Richard Thompson, Christopher T. Lee, Gary D. Lopaschuk, Lakshmi Puttagunta, Sandra Bonnet, Gwyneth Harry, Kyoko Hashimoto, Christopher J. Porter, Miguel A. Andrade, Bernard Thebaud, Evangelos D. Michelakis
|
| |
Med Hypotheses (11 October 2006)
|
| |
|
| |
Nutr Neurosci, Vol. 8, No. 3. (June 2005), pp. 155-160.
|
| |
Acta Psychiatr Scand Suppl, No. 417. (2003), pp. 65-71.
|
| |
|
| |
J Clin Endocrinol Metab, Vol. 88, No. 1. (1 January 2003), pp. 450-458.
|
| |
Experimental Biology and Medicine, Vol. 228, No. 5. (1 May 2003), pp. 506-513.
|
| |
Neuropharmacology, Vol. 34, No. 10. (October 1995), pp. 1327-1333.
|
| |
J. Neurosci., Vol. 6, No. 8. (1 August 1986), pp. 2240-2244.
|
| |
J Neurochem, Vol. 96, No. 2. (January 2006), pp. 396-406.
|
| |
Cancer Res, Vol. 66, No. 7. (1 April 2006), pp. 3480-3484.
|
| |
Clin Endocrinol (Oxf), Vol. 59, No. 6. (December 2003), pp. 811-816.
|
| |
PNAS, Vol. 99, No. 23. (12 November 2002), pp. 15089-15094.
by Petra Bittigau, Marco Sifringer, Kerstin Genz, et al.Ellen Reith, Dana Pospischil, Suresh Govindarajalu, Mark Dzietko, Stefanie Pesditschek, Ingrid Mai, Krikor Dikranian, John W. Olney, Chrysanthy Ikonomidou
|
| |
J Neurochem, Vol. 76, No. 6. (March 2001), pp. 1814-1822.
|
| |
Int J Neuropsychopharmacol, Vol. 3, No. 4. (December 2000), pp. 311-314.
|
| |
|
| |
|
| |
Hear Res, Vol. 175, No. 1-2. (January 2003), pp. 45-53.
|
| |
J Neurochem, Vol. 20, No. 3. (March 1973), pp. 909-912.
|
| |
Acta Physiol Lat Am, Vol. 32, No. 4. (1982), pp. 277-285.
|
| |
Arzneimittelforschung, Vol. 35, No. 9. (1985), pp. 1350-1352.
|
| |
Pharmacol Biochem Behav, Vol. 42, No. 4. (August 1992), pp. 859-864.
|
| |
Acta Physiol Pharmacol Bulg, Vol. 10, No. 4. (1984), pp. 6-15.
|
| |
Eksp Klin Farmakol, Vol. 63, No. 2. (r 2000), pp. 9-11.
|
| |
J Affect Disord, Vol. 1, No. 4. (December 1979), pp. 227-235.
|
| |
Eur Neuropsychopharmacol, Vol. 5, No. 4. (December 1995), pp. 527-529.
|
| |
Environ Sci Technol, Vol. 39, No. 9. (1 May 2005), pp. 3176-3185.
|
| |
|
| |
|
| |
Neurosci Lett, Vol. 383, No. 1-2. (9 2005), pp. 145-150.
|
| |
|
| |
|
| |
Mol Cell Biochem, Vol. 267, No. 1-2. (December 2004), pp. 39-46.
|
| |
J Clin Psychopharmacol, Vol. 21, No. 2. (April 2001), pp. 131-138.
|
| |
|
| |
Psychopharmacology (Berl), Vol. 75, No. 3. (1981), pp. 258-261.
|
| |
J Clin Psychopharmacol, Vol. 18, No. 5. (October 1998), pp. 364-372.
|
| |
|
| |
|
| |
|
| |
Br J Nutr, Vol. 85 Suppl 2 (May 2001)
|
| |
Ann N Y Acad Sci, Vol. 861 (15 December 1998), pp. 204-216.
|
| |
J Gerontol A Biol Sci Med Sci, Vol. 60, No. 3. (March 2005), pp. 275-279.
|